Refinement of a radioreceptor binding assay for nicotinic acid adenine dinucleotide phosphate

The measurement of changes in nicotinic acid adenine dinucleotide phosphate (NAADP) levels in cells has been, and remains, key to the investigation of the functions of NAADP as a Ca2+-releasing second messenger. Here we provide details of how to isolate NAADP from cells by extraction with perchloric...

Full description

Saved in:
Bibliographic Details
Published inAnalytical biochemistry Vol. 371; no. 1; pp. 26 - 36
Main Authors Lewis, Alexander M., Masgrau, Roser, Vasudevan, Sridhar R., Yamasaki, Michiko, O’Neill, John S., Garnham, Clive, James, Kristin, Macdonald, Andrew, Ziegler, Mathias, Galione, Antony, Churchill, Grant C.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2007
Academic Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The measurement of changes in nicotinic acid adenine dinucleotide phosphate (NAADP) levels in cells has been, and remains, key to the investigation of the functions of NAADP as a Ca2+-releasing second messenger. Here we provide details of how to isolate NAADP from cells by extraction with perchloric acid and then measure the NAADP using a radioreceptor assay. We demonstrate that NAADP is neither generated nor broken down during sample processing conditions and that radioreceptor assay is highly selective for the detection of NAADP under cell extract conditions. Furthermore, a number of improvements, such as solid-state detection of the radioactivity, are incorporated to enhance the safety of the procedure. Finally, we have developed a new method to prevent the endogenous metabolism of NAADP by chelating Ca2+ with bis-(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA), thereby reducing the difficulty of catching a small transient rise in NAADP levels. In summary, we have refined and improved a method for measuring NAADP levels and presented it in a manner accessible to a wide range of laboratories. It is expected that this will enhance research in the NAADP field.
Bibliography:These authors contributed equally to this work.
Current address: ResVerLogix Corporation, Calgary, Alberta T2L 2K7, Canada.
Current address: Institut de Neurosciences, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès (Barcelona), Catalonia, Spain.
Current address: MRC Laboratory of Molecular Biology, Neurobiology Division, Cambridge CB2 2QH, UK.
Current address: Department of Neurobiology and Behavior, University of California, Irvine, Irvine, CA 92697, USA.
ISSN:0003-2697
1096-0309
DOI:10.1016/j.ab.2007.08.030